论文部分内容阅读
目的:探讨加速康复外科（ERAS）在妇科良性肿瘤腹腔镜手术中应用的可行性和安全性。方法:选择2017年1月至2018年5月在安徽省宿州市立医院行手术治疗的妇科良性肿瘤患者160例，其中采用ERAS模式手术患者80例为ERAS组；采用传统模式手术患者80例为对照组。比较两组患者手术时间、术后出血量、术后首次排气时间、术后并发症发生率以及术后3、6、12、24 h疼痛视觉模拟评分（VAS评分），同时比较两组术后平均住院时间、平均住院费用。结果:两组手术时间和术中出血量比较差异无统计学意义（n P>0.05）。两组术后并发症发生率比较差异无统计学意义（n P>0.05）。ERAS组较对照组术后首次排气时间显著缩短[（9.8 ± 2.7）h比（19.1 ± 4.0）h]（n P0.05). The postoperative exhaust time in ERAS group was shorter than that in control group [(9.8 ± 2.7) h vs. (19.1 ± 4.0) h] (n P<0.05). The scores of VAS at postoperative 12, 24 h were lower than those in control group [(1.9 ± 0.7) scores vs. (4.2 ± 0.8) scores, (1.3 ± 0.4) scores vs. (3.5 ± 0.9) scores] (n P<0.05). Four patients in control group were injected with pethidine and no patients in ERAS group used pethidine, and the rate of using pethidine in two groups had significant difference [0 vs. 5.0%(4/80)](n P<0.05). The average hospital stay, average hospitalization expenses in ERAS group were lower than those in control group [(3.9 ± 0.7) d vs. (5.2 ± 0.9) d, (1.1 ± 0.1) ten thousand Yuan vs. (1.3 ± 0.1) ten thousand Yuan] (n P<0.01).n Conclusions:The ERAS combined with laparoscopic in benign gynecologic tumor is safe and effective during perioperative period, and is worth of expanding.